Floatz logo

CYCLOSPORIN A

Congenital Amegakaryocytic Thrombocytopenia

University of California, San Franciscoprotein_peptidePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Congenital Amegakaryocytic Thrombocytopenia cohort.

Asset / SponsorPhaseRating
Fludarabine
Fred Hutchinson Cancer Center
Phase 2BB
Busulphan
University of California, San Francisco
Phase 2BB
METHOTREXATE
Fred Hutchinson Cancer Center
Phase 2BB
Thiotepa
Fred Hutchinson Cancer Center
Phase 2BB
TACROLIMUS
Fred Hutchinson Cancer Center
Phase 2B

View all 13 →

Same molecule, other indications

CYCLOSPORIN A is also rated in:

non-Hodgkin lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Chronic Phase Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →